PCM

Penserra Capital Management Portfolio holdings

AUM $7.17B
1-Year Return 49.58%
This Quarter Return
+9.42%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$972M
Cap. Flow %
17.96%
Top 10 Hldgs %
20.49%
Holding
1,158
New
152
Increased
697
Reduced
246
Closed
52

Sector Composition

1 Consumer Discretionary 33.74%
2 Technology 22.72%
3 Communication Services 13.35%
4 Industrials 4.85%
5 Real Estate 4.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MGTX icon
1001
MeiraGTx Holdings
MGTX
$619M
$14K ﹤0.01%
985
-25
-2% -$355
XENE icon
1002
Xenon Pharmaceuticals
XENE
$3.02B
$14K ﹤0.01%
795
-10
-1% -$176
KDNY
1003
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$14K ﹤0.01%
960
-5
-0.5% -$73
ANAB icon
1004
AnaptysBio
ANAB
$613M
$13K ﹤0.01%
615
-15
-2% -$317
ARDX icon
1005
Ardelyx
ARDX
$1.57B
$13K ﹤0.01%
2,055
-15
-0.7% -$95
KALV icon
1006
KalVista Pharmaceuticals
KALV
$796M
$13K ﹤0.01%
530
+120
+29% +$2.94K
KNSA icon
1007
Kiniksa Pharmaceuticals
KNSA
$2.65B
$13K ﹤0.01%
720
-20
-3% -$361
RIGL icon
1008
Rigel Pharmaceuticals
RIGL
$742M
$13K ﹤0.01%
387
-16
-4% -$537
RLMD icon
1009
Relmada Therapeutics
RLMD
$54.8M
$13K ﹤0.01%
370
-5
-1% -$176
PSTX
1010
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$13K ﹤0.01%
1,400
-20
-1% -$186
ACIU icon
1011
AC Immune
ACIU
$229M
$12K ﹤0.01%
1,625
-20
-1% -$148
DNTH icon
1012
Dianthus Therapeutics
DNTH
$853M
$12K ﹤0.01%
68
-1
-1% -$176
DTIL icon
1013
Precision BioSciences
DTIL
$59.8M
$12K ﹤0.01%
40
MSA icon
1014
Mine Safety
MSA
$6.67B
$12K ﹤0.01%
83
+8
+11% +$1.16K
RAPT icon
1015
RAPT Therapeutics
RAPT
$214M
$12K ﹤0.01%
70
-1
-1% -$171
EGRX
1016
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$12K ﹤0.01%
290
-10
-3% -$414
MRNS
1017
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12K ﹤0.01%
810
+110
+16% +$1.63K
ISEE
1018
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$12K ﹤0.01%
2,035
-20
-1% -$118
AKBA icon
1019
Akebia Therapeutics
AKBA
$785M
$11K ﹤0.01%
3,480
+160
+5% +$506
ALT icon
1020
Altimmune
ALT
$314M
$11K ﹤0.01%
845
+85
+11% +$1.11K
AVDL
1021
Avadel Pharmaceuticals
AVDL
$1.53B
$11K ﹤0.01%
1,325
-135
-9% -$1.12K
CRNX icon
1022
Crinetics Pharmaceuticals
CRNX
$3.35B
$11K ﹤0.01%
745
-10
-1% -$148
CTMX icon
1023
CytomX Therapeutics
CTMX
$376M
$11K ﹤0.01%
1,475
+415
+39% +$3.1K
GERN icon
1024
Geron
GERN
$893M
$11K ﹤0.01%
7,105
-265
-4% -$410
NGNE icon
1025
Neurogene
NGNE
$285M
$11K ﹤0.01%
48
-1
-2% -$229